ExLibris header image
SFX Logo
Title: Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma
Source:

Blood [0006-4971] Napoli, Cristina yr:2011


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Aquilante, C.L. L. "Development of a warfarin-dosing algorithm in Asian patients: A pharmacogenomic approach." Personalized Medicine 4.1 (2007): 83-86. Link to SFX for this item
2. Burns, Scott K. "Designing pharmacogenomic studies to be fit for purpose." Pharmacogenomics 11.12 (2010): 1657-1667. Link to SFX for this item
3. Pham, Anh-Nhan N. "Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines." The journal of pharmacology and experimental therapeutics 332.3 (2010): 949-58. Link to SFX for this item
4. Samwald, M. "Semantically enabling pharmacogenomic data for the realization of personalized medicine." Pharmacogenomics 13.2 (2012): 201-212. Link to SFX for this item
5. Narayan, V. "Using Naturally Derived Compounds to Combat HIV: A Case for Complementary and Alternative Medicinal Modalities." The FASEB journal 24.1_MeetingAbstracts (2010): 528-. Link to SFX for this item
6. Eyüpoglu, Nic Y. "The x(c) (-) cystine/glutamate antiporter as potential target for therapy of cancer: Yet another cytotoxic anticancer approach?" Journal of cellular physiology 220.2 (2009): 531-2. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.